Prostate Cancer Drugs Market - Global Outlook and Forecast 2022-2028

Prostate Cancer Drugs Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Drugs Overall Market Size
2.1 Global Prostate Cancer Drugs Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prostate Cancer Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Prostate Cancer Drugs Players in Global Market
3.2 Top Global Prostate Cancer Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Drugs Revenue by Companies
3.4 Global Prostate Cancer Drugs Sales by Companies
3.5 Global Prostate Cancer Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prostate Cancer Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prostate Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Drugs Market Size Markets, 2021 & 2028
4.1.2 Hormonal Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.1.5 Targeted Therapy
4.2 By Type - Global Prostate Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Drugs Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Drugs Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Prostate Cancer Drugs Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Drugs Sales, 2017-2022
4.3.2 By Type - Global Prostate Cancer Drugs Sales, 2023-2028
4.3.3 By Type - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Drugs Market Size, 2021 & 2028
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Prostate Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Drugs Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Drugs Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Prostate Cancer Drugs Sales & Forecasts
5.3.1 By Application - Global Prostate Cancer Drugs Sales, 2017-2022
5.3.2 By Application - Global Prostate Cancer Drugs Sales, 2023-2028
5.3.3 By Application - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Drugs Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Drugs Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Prostate Cancer Drugs Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Drugs Sales, 2017-2022
6.3.2 By Region - Global Prostate Cancer Drugs Sales, 2023-2028
6.3.3 By Region - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Prostate Cancer Drugs Revenue, 2017-2028
6.4.2 By Country - North America Prostate Cancer Drugs Sales, 2017-2028
6.4.3 US Prostate Cancer Drugs Market Size, 2017-2028
6.4.4 Canada Prostate Cancer Drugs Market Size, 2017-2028
6.4.5 Mexico Prostate Cancer Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Prostate Cancer Drugs Sales, 2017-2028
6.5.3 Germany Prostate Cancer Drugs Market Size, 2017-2028
6.5.4 France Prostate Cancer Drugs Market Size, 2017-2028
6.5.5 U.K. Prostate Cancer Drugs Market Size, 2017-2028
6.5.6 Italy Prostate Cancer Drugs Market Size, 2017-2028
6.5.7 Russia Prostate Cancer Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Prostate Cancer Drugs Market Size, 2017-2028
6.5.9 Benelux Prostate Cancer Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Prostate Cancer Drugs Sales, 2017-2028
6.6.3 China Prostate Cancer Drugs Market Size, 2017-2028
6.6.4 Japan Prostate Cancer Drugs Market Size, 2017-2028
6.6.5 South Korea Prostate Cancer Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Prostate Cancer Drugs Market Size, 2017-2028
6.6.7 India Prostate Cancer Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Prostate Cancer Drugs Revenue, 2017-2028
6.7.2 By Country - South America Prostate Cancer Drugs Sales, 2017-2028
6.7.3 Brazil Prostate Cancer Drugs Market Size, 2017-2028
6.7.4 Argentina Prostate Cancer Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Prostate Cancer Drugs Sales, 2017-2028
6.8.3 Turkey Prostate Cancer Drugs Market Size, 2017-2028
6.8.4 Israel Prostate Cancer Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Prostate Cancer Drugs Market Size, 2017-2028
6.8.6 UAE Prostate Cancer Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Major Product Offerings
7.1.4 AbbVie Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Astellas Pharma Key News
7.3 Astra Zeneca
7.3.1 Astra Zeneca Corporate Summary
7.3.2 Astra Zeneca Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Major Product Offerings
7.3.4 Astra Zeneca Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Astra Zeneca Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Major Product Offerings
7.4.4 Johnson & Johnson Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Major Product Offerings
7.5.4 Sanofi Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Merck Group
7.7.1 Merck Group Corporate Summary
7.7.2 Merck Group Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Major Product Offerings
7.7.4 Merck Group Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Merck Group Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Prostate Cancer Drugs Major Product Offerings
7.8.4 Novartis Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Prostate Cancer Drugs Major Product Offerings
7.9.4 Amgen Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Amgen Key News
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Corporate Summary
7.10.2 Bayer HealthCare Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Major Product Offerings
7.10.4 Bayer HealthCare Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Bayer HealthCare Key News
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Corporate Summary
7.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Major Product Offerings
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Ferring Pharmaceutical Key News
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Corporate Summary
7.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Janssen Pharmaceuticals Key News
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporate Summary
7.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Endo Pharmaceuticals Key News
7.14 BMS
7.14.1 BMS Corporate Summary
7.14.2 BMS Business Overview
7.14.3 BMS Prostate Cancer Drugs Major Product Offerings
7.14.4 BMS Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.14.5 BMS Key News
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Corporate Summary
7.15.2 Takeda Pharmaceuticals Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Takeda Pharmaceuticals Key News
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Corporate Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Major Product Offerings
7.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Northwest Biotherapeutics Key News
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Corporate Summary
7.17.2 Teva Pharmaceutical Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Major Product Offerings
7.17.4 Teva Pharmaceutical Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Teva Pharmaceutical Key News
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Corporate Summary
7.18.2 Boehringer Ingelheim Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Major Product Offerings
7.18.4 Boehringer Ingelheim Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Boehringer Ingelheim Key News
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Corporate Summary
7.19.2 Foresee Pharmaceuticals Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Foresee Pharmaceuticals Key News
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Corporate Summary
7.20.2 Tokai Pharmaceuticals Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Tokai Pharmaceuticals Key News
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Corporate Summary
7.21.2 Spectrum Pharmaceuticals Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2017-2022)
7.21.5 Spectrum Pharmaceuticals Key News
8 Global Prostate Cancer Drugs Production Capacity, Analysis
8.1 Global Prostate Cancer Drugs Production Capacity, 2017-2028
8.2 Prostate Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prostate Cancer Drugs Supply Chain Analysis
10.1 Prostate Cancer Drugs Industry Value Chain
10.2 Prostate Cancer Drugs Upstream Market
10.3 Prostate Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prostate Cancer Drugs in Global Market
Table 2. Top Prostate Cancer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Prostate Cancer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Prostate Cancer Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Prostate Cancer Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Prostate Cancer Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Prostate Cancer Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Prostate Cancer Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Prostate Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Prostate Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Prostate Cancer Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Prostate Cancer Drugs Sales (K MT), 2023-2028
Table 16. By Application - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Prostate Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Prostate Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Prostate Cancer Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Prostate Cancer Drugs Sales (K MT), 2023-2028
Table 21. By Region - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Prostate Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Prostate Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Prostate Cancer Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Prostate Cancer Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Prostate Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Prostate Cancer Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Prostate Cancer Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Prostate Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Prostate Cancer Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Prostate Cancer Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Prostate Cancer Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Prostate Cancer Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Prostate Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Prostate Cancer Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Prostate Cancer Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Prostate Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Prostate Cancer Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Prostate Cancer Drugs Sales, (K MT), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Prostate Cancer Drugs Product Offerings
Table 48. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Astellas Pharma Corporate Summary
Table 50. Astellas Pharma Prostate Cancer Drugs Product Offerings
Table 51. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Astra Zeneca Corporate Summary
Table 53. Astra Zeneca Prostate Cancer Drugs Product Offerings
Table 54. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Prostate Cancer Drugs Product Offerings
Table 57. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Prostate Cancer Drugs Product Offerings
Table 60. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Prostate Cancer Drugs Product Offerings
Table 63. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Merck Group Corporate Summary
Table 65. Merck Group Prostate Cancer Drugs Product Offerings
Table 66. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Prostate Cancer Drugs Product Offerings
Table 69. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Amgen Corporate Summary
Table 71. Amgen Prostate Cancer Drugs Product Offerings
Table 72. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Bayer HealthCare Corporate Summary
Table 74. Bayer HealthCare Prostate Cancer Drugs Product Offerings
Table 75. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Ferring Pharmaceutical Corporate Summary
Table 77. Ferring Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 78. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Janssen Pharmaceuticals Corporate Summary
Table 80. Janssen Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 81. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Endo Pharmaceuticals Corporate Summary
Table 83. Endo Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 84. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. BMS Corporate Summary
Table 86. BMS Prostate Cancer Drugs Product Offerings
Table 87. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. Takeda Pharmaceuticals Corporate Summary
Table 89. Takeda Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 90. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Northwest Biotherapeutics Corporate Summary
Table 92. Northwest Biotherapeutics Prostate Cancer Drugs Product Offerings
Table 93. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 94. Teva Pharmaceutical Corporate Summary
Table 95. Teva Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 96. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 97. Boehringer Ingelheim Corporate Summary
Table 98. Boehringer Ingelheim Prostate Cancer Drugs Product Offerings
Table 99. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 100. Foresee Pharmaceuticals Corporate Summary
Table 101. Foresee Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 102. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 103. Tokai Pharmaceuticals Corporate Summary
Table 104. Tokai Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 105. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 106. Spectrum Pharmaceuticals Corporate Summary
Table 107. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 108. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 109. Prostate Cancer Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 110. Global Prostate Cancer Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Prostate Cancer Drugs Production by Region, 2017-2022 (K MT)
Table 112. Global Prostate Cancer Drugs Production by Region, 2023-2028 (K MT)
Table 113. Prostate Cancer Drugs Market Opportunities & Trends in Global Market
Table 114. Prostate Cancer Drugs Market Drivers in Global Market
Table 115. Prostate Cancer Drugs Market Restraints in Global Market
Table 116. Prostate Cancer Drugs Raw Materials
Table 117. Prostate Cancer Drugs Raw Materials Suppliers in Global Market
Table 118. Typical Prostate Cancer Drugs Downstream
Table 119. Prostate Cancer Drugs Downstream Clients in Global Market
Table 120. Prostate Cancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prostate Cancer Drugs Segment by Type
Figure 2. Prostate Cancer Drugs Segment by Application
Figure 3. Global Prostate Cancer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Prostate Cancer Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Drugs Revenue in 2021
Figure 9. By Type - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Prostate Cancer Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Prostate Cancer Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 19. US Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 24. Germany Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 33. China Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Prostate Cancer Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Prostate Cancer Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Prostate Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Prostate Cancer Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Prostate Cancer Drugs by Region, 2021 VS 2028
Figure 50. Prostate Cancer Drugs Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs